Canaccord Genuity Maintains Buy on Omada Health, Raises Price Target to $28
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Richard Close maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price target from $24 to $28.
Canaccord Genuity analyst Richard Close maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price target from $24 to $28.